HRA Pharma creates
innovative products
to fill therapeutic gaps
in reproductive health
and endocrinology.

• August 13, 2010

  Paris, France
  FDA grants approval of ella^® for emergency contraception

• July 15, 2010

  Paris, France
  Ulipristal acetate (ellaOne^®) significantly reduces pregnancy risk versus levonorgestrel for oral emergency contraception